BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 21411269)

  • 1. Pathophysiology of inflammatory and autoimmune myopathies.
    Dalakas MC
    Presse Med; 2011 Apr; 40(4 Pt 2):e237-47. PubMed ID: 21411269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review: An update on inflammatory and autoimmune myopathies.
    Dalakas MC
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):226-42. PubMed ID: 21155862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
    Dalakas MC
    Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and therapies of immune-mediated myopathies.
    Dalakas MC
    Autoimmun Rev; 2012 Jan; 11(3):203-6. PubMed ID: 21619945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on idiopathic inflammatory myopathies.
    Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of primary inflammatory myopathies].
    Benveniste O; Squier W; Boyer O; Hilton-Jones D; Herson S
    Presse Med; 2004 Nov; 33(20):1444-50. PubMed ID: 15611679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
    Eymard B
    Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features.
    Khan S; Christopher-Stine L
    Rheum Dis Clin North Am; 2011 May; 37(2):143-58, v. PubMed ID: 21444016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
    Dourmishev LA
    Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
    Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
    J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
    Dalakas MC
    Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
    Gherardi RK
    Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyositis: an overdiagnosed entity.
    van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M
    Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
    Das L; Blumbergs PC; Manavis J; Limaye VS
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyositis and dermatomyositis.
    Dalakas MC; Hohlfeld R
    Lancet; 2003 Sep; 362(9388):971-82. PubMed ID: 14511932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New classifications and pathophysiology of the inflammatory myopathies].
    Benveniste O; Dubourg O; Herson S
    Rev Med Interne; 2007 Sep; 28(9):603-12. PubMed ID: 17462794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of interferon-gamma on skeletal muscle cell biology].
    Hou C; Baba-Amer Y; Bencze M; Relaix F; Jérôme Authier F
    Med Sci (Paris); 2018 Nov; 34 Hors série n°2():35-38. PubMed ID: 30418144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathological diagnosis of specific inflammatory myopathies.
    Carpenter S; Karpati G
    Brain Pathol; 1992 Jan; 2(1):13-9. PubMed ID: 1341942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.